biostudies-literatureBosio CEuropean Union’s Horizon 2020 Research and Innovation Programe094351https://www.ebi.ac.uk/biostudies/studies/S-EPMC11927486biostudies-literatureUnknown15(3)<h4>Objective</h4>To examine patient engagement (PE) levels of atrial fibrillation (AF) patients with multimorbidity, to identify distinct personas based on sociodemographic and clinical characteristics, as well as engagement levels, and to compare PE in disease management with health-related quality of life, medication adherence, and perceptions of care quality.<h4>Design</h4>A cross-sectional survey.<h4>Setting</h4>Data were collected through an online survey platform between 31 May 2022 and 31 January 2023 from five European countries (Denmark, Italy, Romania, Spain and the UK).<h4>Participants</h4>The study involved 659 AF patients older than 18 years who were diagnosed with one or more concomitant chronic health conditions.<h4>Primary and secondary outcome measures</h4>The survey focuBMJ openExploring patient engagement in atrial fibrillation with multimorbidity: impact on quality of life, medication adherence and healthcare perceptions-a multicountry cross-sectional study.PMC11927486899871Ainsworth JGraffigna GJohnsen SPFerri ABosio CLeo DAFFIRMO Project ConsortiumMaggi SKalra DJensen CLane DDavila COnder GOrtuno MRuppe GMaggioni APVetrano DLUniversitet AUsta DPetrovic MDan GAMarczyk JTrevisan CfalseExploring patient engagement in atrial fibrillation with multimorbidity: impact on quality of life, medication adherence and healthcare perceptions-a multicountry cross-sectional study.<h4>Objective</h4>To examine patient engagement (PE) levels of atrial fibrillation (AF) patients with multimorbidity, to identify distinct personas based on sociodemographic and clinical characteristics, as well as engagement levels, and to compare PE in disease management with health-related quality of life, medication adherence, and perceptions of care quality.<h4>Design</h4>A cross-sectional survey.<h4>Setting</h4>Data were collected through an online survey platform between 31 May 2022 and 31 January 2023 from five European countries (Denmark, Italy, Romania, Spain and the UK).<h4>Participants</h4>The study involved 659 AF patients older than 18 years who were diagnosed with one or more concomitant chronic health conditions.<h4>Primary and secondary outcome measures</h4>The survey focu2025-01-01T00:00:00Z2025 Mar2025-07-06T03:04:28.721Z2025-07-06T03:04:28.721ZS-EPMC119274864010770010.1136/bmjopen-2024-094351